M K Proteins Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
MKPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
M K Proteins' Board approved unaudited results for Q1 FY26 (quarter ended June 30, 2025). Revenue from operations more than doubled to Rs. 11,494.60 lacs from Rs. 5,733.30 lacs in Q1 FY25. Profit after tax rose about 42% to Rs. 351.32 lacs from Rs. 248.13 lacs, with EPS at Rs. 0.09 versus Rs. 0.07. The company also accepted the resignation of statutory auditor M/s KRA & Co. effective August 12, 2025, with no concerns flagged, and appointed M/s Subhash Sajal & Associates to fill the casual vacancy until the next AGM. Separately, M/s J.P. Jagdev & Co. was appointed as Secretarial Auditor for five years from FY25-26 to FY29-30. Full-year FY25 results show revenue of Rs. 26,770.60 lacs (up ~9% YoY) but PAT of Rs. 839.74 lacs, down about 25% from Rs. 1,121.19 lacs in FY24.
Strong quarter-on-quarter top-line doubling and ~42% PAT growth are positive signals for shareholders, though FY25 full-year profit had declined. The mid-year auditor change, while routine in this case (no issues raised), warrants a watch for any future disclosures on audit observations.